NanoString Technologies, Inc.

NSTG

$36.67

+78.89% (1 year change)

Avg closing price

Price range

Market Cap

$1.73 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

-

Total revenue in the last quarter.

Net Income

-

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$-1.73

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

-

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

-23.18x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

-

Earnings before interest expenses and taxes in the last quarter.

Employees

551

The number of full time employees.

Revenue & Earnings

Balance Sheet

NanoString Technologies, Inc.

NanoString Technologies, Inc. engages in the development and commercialization of instrument and services for profiling of genes and proteins from tissue sample. It offers GeoMx Digital Spatial Profiler, nCounter Systems, analysis solutions, gene expression panels, Vantage 3D Assays, miRNA Assays, custom solutions, and Sample Prep and nCounter Consumables. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.

News

NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares

NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the closing of its previous...

Business Wire Business Wire, 11 days ago
OnRamp Bio and NanoString Announce Global Availability of ROSALIND® for nCounter Users

OnRamp Bio and NanoString Announce Global Availability of ROSALIND® for nCounter Users

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cl...

Business Wire Business Wire, 16 days ago
NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock

NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock

SEATTLE--(BUSINESS WIRE)--NanoString announces pricing of upsized public stock offering.

Business Wire Business Wire, 16 days ago